Page last updated: 2024-09-03

fr 900482 and fr 66973

fr 900482 has been researched along with fr 66973 in 2 studies

Compound Research Comparison

Studies
(fr 900482)
Trials
(fr 900482)
Recent Studies (post-2010)
(fr 900482)
Studies
(fr 66973)
Trials
(fr 66973)
Recent Studies (post-2010) (fr 66973)
29041811

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aurrecoechea, N; Jung, KY; Paleo, MR; Rapoport, H1
Huso, TH; Resar, LM1

Reviews

1 review(s) available for fr 900482 and fr 66973

ArticleYear
The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
    Expert opinion on therapeutic targets, 2014, Volume: 18, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Differentiation; Chromatin; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Disease Progression; Drug Screening Assays, Antitumor; Flavonoids; Gene Expression Regulation, Neoplastic; Genetic Therapy; HMGA1a Protein; HMGA1b Protein; Humans; Mice; Molecular Targeted Therapy; Nanoparticles; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Oxazines; Piperidines; RNA, Small Interfering; Stem Cells

2014

Other Studies

1 other study(ies) available for fr 900482 and fr 66973

ArticleYear
Formal enantiospecific synthesis of (+)-FR900482.
    The Journal of organic chemistry, 2003, Jan-10, Volume: 68, Issue:1

    Topics: Antibiotics, Antineoplastic; Catalysis; Combinatorial Chemistry Techniques; Crystallography, X-Ray; Epoxy Compounds; Glycine; Molecular Structure; Oxazines; Oxidation-Reduction; Stereoisomerism; Structure-Activity Relationship

2003